Average Co-Inventor Count = 7.07
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Glaxosmithkline Intellectual Property (no.2) Limited (15 from 92 patents)
2. Glaxo Group Limited (4 from 1,168 patents)
3. Other (2 from 832,843 patents)
4. Glaxosmithkline Intellectual Property Development Limited (2 from 230 patents)
23 patents:
1. 11478478 - 2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
2. 11319307 - 2,3-dihydrobenzohurans as bromodomain inhibitors
3. 11273146 - Benzofuran derivatives and their use as bromodomain inhibitors
4. 10966961 - Pyrazole derivatives as bromodomain inhibitors
5. 10934272 - Pyridyl derivatives as bromodomain inhibitors
6. 10927080 - Pyridinone dicarboxamide for use as bromodomain inhibitors
7. 10849897 - Pyridyl derivatives as bromodomain inhibitors
8. 10844015 - Pyridine dicarboxamide derivatives as bromodomain inhibitors
9. 10815218 - Benzoimidazole derivatives as PAD4 inhibitors
10. 10583139 - 2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
11. 10583112 - Benzo[b]furans as bromodomain inhibitors
12. 10471050 - 2-OXO-1,2-dihydropyridine-3,5-dicarboxamide compounds as bromodomain inhibitors
13. 10428026 - Pyridinone dicarboxamide for use as bromodomain inhibitors
14. 10407407 - Benzoimidazole derivatives as PAD4 inhibitors
15. 10370356 - Pyridinone dicarboxamide for use as bromodomain inhibitors